Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials

Yating Wang, Zhuoxin Sun, Arthi Sridhar, Suresh S. Ramalingam, Heather A. Wakelee, David E. Gerber

Open source

DOI
10.1016/j.lungcan.2026.109304
Published
2026-04
Container
Lung Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2026.109304,
  title = {Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials},
  author = {Yating Wang and Zhuoxin Sun and Arthi Sridhar and Suresh S. Ramalingam and Heather A. Wakelee and David E. Gerber},
  year = {2026},
  journal = {Lung Cancer},
  doi = {10.1016/j.lungcan.2026.109304},
  url = {https://doi.org/10.1016/j.lungcan.2026.109304}
}

RIS

TY  - JOUR
TI  - Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials
AU  - Yating Wang
AU  - Zhuoxin Sun
AU  - Arthi Sridhar
AU  - Suresh S. Ramalingam
AU  - Heather A. Wakelee
AU  - David E. Gerber
PY  - 2026
JO  - Lung Cancer
DO  - 10.1016/j.lungcan.2026.109304
UR  - https://doi.org/10.1016/j.lungcan.2026.109304
ER  - 

APA

Wang, Y., Sun, Z., Sridhar, A., Ramalingam, S. S., Wakelee, H. A., & Gerber, D. E. (2026). Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials. Lung Cancer. https://doi.org/10.1016/j.lungcan.2026.109304

Source records